New York, Jan. 30, 2020 (GLOBE NEWSWIRE) — Univest Securities, LLC, a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today announced the pricing and trading of the initial public offering (“IPO”) for its client AnPac Bio-Medical Science Co., Ltd

SAN JOSE, Calif., Jan. 30, 2020 /PRNewswire/ — Anpac Bio-Medical Science Co., Ltd.  (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its initial public offering of 1,333,360 American depositary shares (“ADSs”) at […]

AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, announced terms for its US IPO on Friday. The Lishui, China-based company plans to raise $22 million by offering 1.7 million ADSs at a price range of $12 to $14. Insiders intend to purchase $2 million worth of shares in the offering. At the midpoint […]

New York, Oct. 31, 2019 (GLOBE NEWSWIRE) — Univest Securities, LLC, a FINRA and SIPC member full-service investment bank and securities broker-dealer firm, today announced the closing of previously announced the initial public offering (“IPO”) for its client Happiness Biotech Group Limited (“Happiness” or Nasdaq: HAPP), marking the second Nasdaq IPO underwritten as the lead-left underwriter and the sole book-runner by Uinvest in 2019. On a firm commitment basis, Univest sold, on behalf of Happiness, 2,000,000 shares of its ordinary shares at of $5.50 per share for a total of $11,000,000 in gross proceeds before fees and expenses. Happiness’s ordinary shares began trading on the Nasdaq Capital Market (“Nasdaq”) on Friday, October 25th, 2019 under the trading symbol “HAPP”.